Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.49 |
| ▸ | MGLL | Q99685 | 5/20 | 0.48 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CASP3 | P42574 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.45 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.45 |
| ▸ | P2RY14 | Q15391 | 4/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.43 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.42 |
| ▸ | DUSP1 | P28562 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20469804 | 0.91 | NPC1 (0.47) | MGLLNPC1HSP90AA1RAB9AKMT2A | |
| SCHEMBL23542090 | 0.91 | NPC1 (0.52) | FASNMGLLNPC1HSP90AA1RAB9A | |
| SCHEMBL23542079 | 0.90 | RAB9A (0.55) | MGLLNPC1HSP90AA1RAB9AKMT2A | |
| SCHEMBL20469732 | 0.90 | RAB9A (0.55) | MGLLNPC1HSP90AA1RAB9AKMT2A | |
| SCHEMBL23542095 | 0.90 | RAB9A (0.47) | MGLLNPC1HSP90AA1RAB9AKMT2A | |
| SCHEMBL23542070 | 0.90 | RAB9A (0.55) | MGLLNPC1HSP90AA1RAB9AKMT2A | |
| SCHEMBL20469800 | 0.89 | NPC1 (0.46) | MGLLNPC1HSP90AA1RAB9AKMT2A | |
| SCHEMBL20469759 | 0.89 | NPC1 (0.46) | MGLLNPC1HSP90AA1RAB9AKMT2A | |
| SCHEMBL20469657 | 0.88 | MGLL (0.49) | MGLLNPC1HSP90AA1RAB9AKMT2A | |
| SCHEMBL20469754 | 0.88 | MGLL (0.49) | MGLLNPC1HSP90AA1RAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11040963-B2 | Piperazine derivatives for influenza virus inhibitions | JANSSEN VACCINES & PREVENTION B.V. (NL) | 2021-06-22 | — | — | US | disclosed |
| WO-2018141854-A1 | PIPERAZINE DERIVATIVES FOR INFLUENZA VIRUS INHIBITION | JANSSEN VACCINES & PREVENTION B.V. (NL) | 2018-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11040963-B2 | Piperazine derivatives for influenza virus inhibitions | HAVCR2, BAZ2A, MAVS | FASN 3949/4885MGLL 2930/4885NPC1 720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.